Cansortium OTC Stock Top Insiders

CNTMF Stock  USD 0.08  0  2.35%   
Cansortium employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 24 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Cansortium's management performance can provide insight into the company performance.
Samantha Hymes  Insider
Ex Operations
Jennifer McCaffertyFernandez  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansortium. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.

Cansortium Management Team Effectiveness

The company has return on total asset (ROA) of 0.021 % which means that it generated a profit of $0.021 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2825) %, meaning that it generated substantial loss on money invested by shareholders. Cansortium's management efficiency ratios could be used to measure how well Cansortium manages its routine affairs as well as how well it operates its assets and liabilities.

Cansortium Workforce Comparison

Cansortium is rated fourth in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 2,342. Cansortium adds roughly 10.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.29) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Cansortium Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Cansortium Price Series Summation is a cross summation of Cansortium price series and its benchmark/peer.

Cansortium Notable Stakeholders

A Cansortium stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cansortium often face trade-offs trying to please all of them. Cansortium's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cansortium's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Cansortium Management Performance

The success or failure of an entity such as Cansortium often depends on how effective the management is. Cansortium management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cansortium management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cansortium management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida. Cansortium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
The data published in Cansortium's official financial statements typically reflect Cansortium's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Cansortium's quantitative information. For example, before you start analyzing numbers published by Cansortium accountants, it's essential to understand Cansortium's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.

Cansortium Workforce Analysis

Traditionally, organizations such as Cansortium use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cansortium within its industry.

Cansortium Manpower Efficiency

Return on Cansortium Manpower

Revenue Per Employee6.5M
Revenue Per Executive6.5M
Net Loss Per Employee1.9M
Net Loss Per Executive1.9M

Complementary Tools for Cansortium OTC Stock analysis

When running Cansortium's price analysis, check to measure Cansortium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansortium is operating at the current time. Most of Cansortium's value examination focuses on studying past and present price action to predict the probability of Cansortium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cansortium's price. Additionally, you may evaluate how the addition of Cansortium to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios